Predictive value of a combined inflammatory score based on laboratory data within 24 hours of admission for 28-day mortality in patients with sepsis: a retrospective cohort study
This retrospective cohort study of 248 sepsis patients found that while a combined inflammatory score based on procalcitonin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio is independently associated with 28-day mortality, it offers only limited incremental prognostic value beyond established clinical indicators such as the APACHE II score, lactate, albumin, and sex.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human body as a bustling city under siege. When an infection strikes, the city's defense force—the immune system—rallies to fight the invaders. Sometimes, this defense goes into overdrive, causing chaos and damaging the city's own infrastructure. This runaway reaction is called sepsis, and it's a medical emergency where the body's response to infection becomes life-threatening. To figure out which patients are in the most danger, doctors act like detectives, looking for clues in the blood. They check for inflammatory markers, which are like smoke signals or sirens indicating how hard the immune system is fighting. Two common tools are Procalcitonin (PCT), a protein that spikes when bacteria are present, and ratios like the Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR). These ratios compare different types of white blood cells; think of them as counting how many "attackers" (neutrophils/monocytes) are swarming versus how many "peacekeepers" (lymphocytes) are left standing. The big question in emergency rooms is: Can we combine these smoke signals into a single, super-smart alarm system to predict who might not survive the next month?
This paper is the story of a team of medical detectives from Suining Central Hospital in China who decided to build that very alarm system. They looked back at the records of 248 adult patients who walked into their emergency department with sepsis between January 2024 and April 2026. Their goal was to create a simple "Inflammatory Score" by adding up points for three specific clues found in the blood within the first 24 hours of admission: high PCT, high NLR, and high MLR. If a patient's blood showed high levels of any of these, they got a point. The score could range from 0 (no red flags) to 3 (all three alarms blaring).
The team found that this score was indeed a useful clue. Out of the 248 patients, 51 (about 21%) did not survive the 28-day mark. The data showed a clear trend: the higher the score, the higher the risk. Patients with a score of 3 had a 50% chance of dying within 28 days, while those with a score of 0 had a much lower risk of 14%. It's like a weather forecast where a "Level 3 Storm Warning" predicts much worse conditions than a "Level 0."
However, here is the twist in the story. The researchers didn't just look at their new score in isolation; they compared it to the tools doctors already use every day, like the APACHE II score (a complex calculation of how sick a patient is based on vital signs and history), lactate levels (a sign of oxygen starvation in tissues), and albumin levels (a measure of the body's nutritional and protein reserves). When they mixed their new inflammatory score into a model that already included these established tools, the result was a bit of a "meh."
The new score did add a tiny bit of extra information, but not much. The ability of the model to predict who would die improved only slightly, from a score of 0.796 to 0.809. To put that in perspective, if the existing tools were a flashlight that could see 79.6% of the danger in the dark, adding the new score made it a 80.9% flashlight. It's a brighter light, but not a laser beam. The study suggests that while the PCT/NLR/MLR score is a valid indicator of inflammation, it doesn't tell us much more than what we already know from checking how sick the patient is, how well their organs are working, and how much oxygen their tissues are getting.
Interestingly, the study also spotted a curious pattern regarding gender. Female patients were found to have a lower risk of death compared to male patients, even after adjusting for how sick they were. The authors suggest this might be due to differences in how male and female immune systems react, but they admit this is just a hypothesis for future research, not a proven rule.
In the end, the paper concludes that this combined inflammatory score is a helpful sidekick, not the main hero. It can support doctors in the emergency room by confirming that a patient is under heavy inflammatory stress, but it shouldn't replace the established, heavy-duty tools like the APACHE II score or lactate measurements. The best approach, the authors suggest, is to use these routine blood markers as part of a bigger picture, combining them with established signs of severity and organ function to get the clearest view of a patient's fate. The score is a useful piece of the puzzle, but it doesn't solve the whole mystery on its own.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.